Patents Assigned to MUREX PHARMACEUTICALS
  • Anti-Tumor Activity of an Oncolytic Adenovirus-Delivered Oncogene siRNA
    Publication number: 20070258952
    Abstract: The present invention includes compositions and methods for the knockdown of one or more genes to a target cell in need of gene therapy by using an siRNA transgene that is integrated into a replication-competent, oncolytic adenovirus.
    Type: Application
    Filed: May 4, 2007
    Publication date: November 8, 2007
    Applicants: BAYLOR RESEARCH INSTITUTE, MUREX PHARMACEUTICALS, BAYLOR UNIVERSITY
    Inventors: Alex W. Tong, Yu An Zhang, John J. Nemunaitis, Yuqiao Shen, Po-hsun Chen, Shirley K. Samuel